CVS HEALTH Corp financial data

Symbol
CVS on NYSE
Industry
Retail-Drug Stores and Proprietary Stores
Location
One Cvs Dr., Woonsocket, RI
Fiscal year end
December 31
Former names
CVS CAREMARK CORP (to 9/3/2014), CVS/CAREMARK CORP (to 5/8/2007), CVS CORP (to 3/22/2007), MELVILLE CORP (to 1/10/1997)
Latest financial report
10-Q - Q1 2025 - May 1, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 82.2 % -2.75%
Quick Ratio 20.4 % -5.34%
Debt-to-equity 235 % -0.48%
Return On Equity 6.97 % -29%
Return On Assets 2.08 % -28.7%
Operating Margin 2.54 % -27%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.27B shares +0.77%
Common Stock, Shares, Outstanding 1.26B shares +0.8%
Entity Public Float 74.1B USD -16.3%
Common Stock, Value, Issued 18M USD 0%
Weighted Average Number of Shares Outstanding, Basic 1.26B shares +0.08%
Weighted Average Number of Shares Outstanding, Diluted 1.26B shares -0.24%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 379B USD +4.99%
Costs and Expenses 369B USD +6.02%
Operating Income (Loss) 9.62B USD -23.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 7.19B USD -27.2%
Income Tax Expense (Benefit) 1.94B USD -23.1%
Net Income (Loss) Attributable to Parent 5.28B USD -27.9%
Earnings Per Share, Basic 4.2 USD/shares -26.4%
Earnings Per Share, Diluted 4.19 USD/shares -26.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.1B USD +2.81%
Accounts Receivable, after Allowance for Credit Loss, Current 39.6B USD +23%
Inventory, Net 17.4B USD +6.36%
Other Assets, Current 3.53B USD -39.4%
Assets, Current 73.2B USD +8.48%
Property, Plant and Equipment, Net 13B USD +3.14%
Operating Lease, Right-of-Use Asset 15.7B USD -7.87%
Intangible Assets, Net (Excluding Goodwill) 26.6B USD -7.65%
Goodwill 91.2B USD -0.08%
Other Assets, Noncurrent 5.23B USD +8.96%
Assets 256B USD +2.34%
Accrued Liabilities, Current 22.4B USD +0.09%
Contract with Customer, Liability, Current 65M USD -44.4%
Liabilities, Current 89B USD +6.77%
Long-term Debt and Lease Obligation 59B USD +2.33%
Deferred Income Tax Liabilities, Net 3.66B USD -12.4%
Operating Lease, Liability, Noncurrent 14.6B USD -7.29%
Other Liabilities, Noncurrent 5.42B USD -12.7%
Liabilities 178B USD +1.64%
Common Stocks, Including Additional Paid in Capital 49.8B USD +1.28%
Accumulated Other Comprehensive Income (Loss), Net of Tax 59M USD
Retained Earnings (Accumulated Deficit) 63.8B USD +3.06%
Stockholders' Equity Attributable to Parent 76.9B USD +4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 77.1B USD +3.99%
Liabilities and Equity 256B USD +2.34%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.56B USD -7.08%
Net Cash Provided by (Used in) Financing Activities -2.33B USD -90.1%
Net Cash Provided by (Used in) Investing Activities -762M USD +63.6%
Common Stock, Shares Authorized 3.2B shares 0%
Common Stock, Shares, Issued 1.78B shares +0.45%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.46B USD -7.59%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.3B USD +2.37%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.01B USD -2.97%
Deferred Tax Assets, Valuation Allowance 301M USD -21.8%
Operating Lease, Liability 16.7B USD -6.33%
Payments to Acquire Property, Plant, and Equipment 743M USD +5.39%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 5.68B USD -27.7%
Lessee, Operating Lease, Liability, to be Paid 21.2B USD -7.28%
Operating Lease, Liability, Current 1.91B USD +0.16%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.53B USD -1.21%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.68B USD -1.22%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.54B USD -10.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.34B USD -1.1%
Deferred Tax Assets, Operating Loss Carryforwards 272M USD -33.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100K shares 0%
Unrecognized Tax Benefits 424M USD -2.75%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.17B USD -0.64%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 2.02B USD +0.25%
Depreciation, Depletion and Amortization 1.15B USD +1.41%
Deferred Tax Assets, Net of Valuation Allowance 7.61B USD -4.94%
Interest Expense 2.79B USD +21.6%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%